Pentraxin 3/TSG-14 RNAi Summary
Homo sapiens ST7 overlapping transcript 2 (antisense non-coding RNA) (ST7OT2) on chromosome 7
Packaging, Storage & Formulations
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles.
Concentration is not relevant for this product. Please see the protocols for proper use of this product.
This product is produced by and distributed for Abnova, a company based in Taiwan.
Alternate Names for Pentraxin 3/TSG-14 RNAi
- alpha-induced protein 5
- pentaxin-related gene, rapidly induced by IL-1 beta, tumor necrosis factor
- Pentaxin-related protein PTX3
- pentraxin 3, long
- pentraxin-related gene, rapidly induced by IL-1 beta
- pentraxin-related protein PTX3
- TNF alpha-induced protein 5
- TSG-14pentaxin-related gene, rapidly induced by IL-1 beta
- Tumor necrosis factor alpha-induced protein 5
- tumor necrosis factor, alpha-induced protein 5
- Tumor necrosis factor-inducible gene 14 protein
- tumor necrosis factor-inducible protein TSG-14
Position of the Chimera RNAi. The related RNAi products listed were designed from different accesion number but sharing the same RNAi sequence. Chimera RNA interference (chimera RNAi) is process by which small interfering RNA/DNA chimera triggers the destruction of mRNA for the original gene. The discovery work, design, and application of chimera RNAi has been pioneered by Professor Kaoru Saigo and Dr. Kumiko Ui-Tei at the University of Tokyo. Chimera RNAi has many advantages over the conventional siRNAs. First, it has been demonstrated to have reliable knock-down for over 10,000 human genes. Because the human genome is composed of an intricate, genetic network, chimera RNAi's unique design has successfully obviated the off-target effects including microRNA-based influence. Another advantage of the chimera RNAi technology is its effectiveness at low concentrations (0.5nM to 5nM); only mRNA is destroyed so genomic genes are not affected. Finally, having both the sense and anti-sense strands consisting RNA/DNA chimera, it offers much greater compound stability for streamlining in vitro and in vivo assays and applications while minimizing interferon induction and other adverse reactions.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. RNAi are guaranteed
for 3 months from date of receipt.
Customers Who Viewed This Item Also Viewed...
Species: Hu, Mu
Applications: WB, Simple Western
Species: Hu, Mu, Rt
Applications: WB, ELISA, S-ELISA
Applications: WB, IHC, IHC-P
Species: Hu, Mu
Applications: WB, IHC
Applications: WB, Flow, IA, ICC/IF, IHC, IHC-Fr, IHC-P, IP
Species: Hu, Mu, Rt, Bv, Ca, Ch, Xp
Species: Hu, Mu, Rt
Applications: WB, Simple Western, IHC, IHC-P
Applications: WB, Func, PAGE
Species: Hu, Mu, Rt, Dr, Ma
Applications: WB, Simple Western, ICC/IF, IHC, IHC-Fr, IHC-P, IHC-FrFl
Publications for Pentraxin 3/TSG-14 RNAi (H00005806-R01) (0)
There are no publications for Pentraxin 3/TSG-14 RNAi (H00005806-R01).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for Pentraxin 3/TSG-14 RNAi (H00005806-R01) (0)
There are no reviews for Pentraxin 3/TSG-14 RNAi (H00005806-R01).
By submitting a review earn points towards our Rewards Program.
- 250 points for product review
- 500 additional points for an image with your product review
- Double points (500) if you are the first to review this product
- Double points (1000) if you are the first to review this product with an image
FAQs for Pentraxin 3/TSG-14 RNAi (H00005806-R01) (0)
Additional Pentraxin 3/TSG-14 RNAi Products
Related Products by Gene
, PENTRAXIN 3
Bioinformatics Tool for Pentraxin 3/TSG-14 RNAi (H00005806-R01)
Discover related pathways, diseases and genes to Pentraxin 3/TSG-14 RNAi (H00005806-R01). Need help?
Read the Bioinformatics Tool Guide
for instructions on using this tool.
Blogs on Pentraxin 3/TSG-14